Key Points Below-consensus Q2’24 EBITDA and EPS on q-o-q pricing and volume declines in AC segment Q3’24 guidance below consensus. FY2024 guidance range cut to below consensus levels. Near-term commentary mixed We have...
Key Points Q3’24 EBITDA and EPS beat on margin and pricing gains. Q4’24 guidance midpoint below consensus Higher y-o-y EBITDA in Americas and Europe offset somewhat by lower Asia and Middle East...
Key Points We’re reiterating our Overweight rating on shares of HWM after yesterday’s outstanding 2Q earnings release. Our target price rises USD18 to USD110 as we increase our forecast and raise...
Key Points Q2 EPS beat but EBITDA miss; global methanol demand grew q-o-q Lower-than-forecasted volumes in all geographies except Egypt and Medicine Hat. G3 start up ahead of schedule We rate Methanex shares...
Key Points Q2’24 EBITDA and EPS miss; Q3’24 and FY2024 guidance range mid-point below consensus Sequentially higher EBITDA margins in PM segment but lower in S&S segment. Strong y-o-y PM segment volume...
Key Points We’re raising our rating on shares of RTX to Overweight post last week’s 2Q earnings report. We’ve also raised our financial forecast for RTX and our target price rises...
Key Points We’re updating our forecast for LHX post Friday’s 2Q24 earnings results, reiterating our Overweight rating, and raising our target price USD13 to USD264. Our revenue forecast increases for both...
Key Points We’re updating our forecast for GD post Wednesday's 2Q24 earnings results and maintaining our Neutral rating, though our target price rises USD4. While our topline forecast increases post excellent growth...